PON2
protein-codingparaoxonase 2, the group of Paraoxonases
Gene summary
This gene encodes a member of the paraoxonase gene family, which includes three known members located adjacent to each other on the long arm of chromosome 7. The encoded protein is ubiquitously expressed in human tissues, membrane-bound, and may act as a cellular antioxidant, protecting cells from oxidative stress. Hydrolytic activity against acylhomoserine lactones, important bacterial quorum-sensing mediators, suggests the encoded protein may also play a role in defense responses to pathogenic bacteria. Mutations in this gene may be associated with vascular disease and a number of quantitative phenotypes related to diabetes. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~30.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PON2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000305.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 5 | 15 | |||
| missense | 47 | 7 | 1 | 55 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 51 | 17 | 6 | 74 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000296.2 | 9 | MANE Select | |
| Ensembl | ENSP00000222572.3 | 9 | MANE Select | |
| RefSeq | NP_001018171.1 | 9 | Standard | |
| Ensembl | ENSP00000404622.2 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Phase I biotransformations, non P450
- Metabolism of lipids
- Synthesis of 5-eicosatetraenoic acids
- Arachidonic acid metabolism
- Metabolism
Biological Process
- response to oxidative stress
- response to toxic substance
- lipoxygenase pathway
- aromatic compound catabolic process
Molecular Function
- arylesterase activity
- identical protein binding
- metal ion binding
- acyl-L-homoserine-lactone lactonohydrolase activity
Cellular Component
- extracellular region
- nucleus
- mitochondrion
- lysosome
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000222572
- Coding exons
- 9
- Length
- 30336
- Individuals with no LoFs
- 125428
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 318
- Defined
- 125748
- p
- 0.00127
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.755 | 154 | 183 | 0.843 | 0.00000893 | 2306 |
| Missense (PolyPhen) | 31 | 36.806 | 0.84225 | 465 | ||
| Synonymous | -0.343 | 73 | 69.4 | 1.05 | 0.00000342 | 697 |
| Loss of Function | 1.49 | 9 | 15.3 | 0.589 | 7.09e-7 | 207 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.0013 | 0.0012 | notable |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.00065 | 0.00065 | rare |
| European (Non-Finnish) | 0.0020 | 0.0019 | notable |
| South Asian | 0.00082 | 0.00082 | rare |
| Other | 0.0015 | 0.0015 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Capable of hydrolyzing lactones and a number of aromatic carboxylic acid esters. Has antioxidant activity. Is not associated with high density lipoprotein. Prevents LDL lipid peroxidation, reverses the oxidation of mildly oxidized LDL, and inhibits the ability of MM-LDL to induce monocyte chemotaxis. {ECO:0000269|PubMed:11579088, ECO:0000269|PubMed:15772423}.;
Recessive Scores
- pRec
- 0.516
Intolerance Scores
- LoFtool
- 0.823
- RVIS EVS
- 0.4
- RVIS percentile EVS
- 76.15
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.996
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | High | High |